Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

NCRI 2017 | The current and future uses of the immunoscore

Jerome Galon • 5 Nov 2017
NCRI 2017
Colorectal Cancer General

The immunoscore is a predictive tool that scores cancer patients based on an evaluation of their adaptive immunity. In this interview, Jerome Galon, PhD, of Cordeliers Research Center, Paris, France, who helped develop the immunoscore, gives an overview of its current usage in the risk stratification of colon cancer patients in Europe, in addition to its potential in other types of cancer and as a predictive biomarker of treatment responses. This video was recorded at the 2017 National Cancer Research Institute (NCRI) Conference, held in Liverpool, UK.

More from Jerome Galon

1:07
Heating up a tumor: modulating the immunoscore
Jerome Galon • 5 Nov 2017
0:35
Tracking an immunoscore throughout treatment
Jerome Galon • 5 Nov 2017
0:36
Presenting the immunoscore
Jerome Galon • 5 Nov 2017
1:59
The immunoscore: a new way of stratifying cancer
Jerome Galon • 5 Nov 2017

Related Videos

1:56
Phase I trial of trastuzumab deruxtecan and neratinib in HER2-altered tumors
Haeseong Park • 8 Apr 2024
2:45
Remaining challenges in treating solid tumors with CAR-Treg therapy
Leonardo Ferreira • 8 Apr 2024
2:01
Engineering chimeric antigen receptor regulatory T cells for treating cancer
Leonardo Ferreira • 8 Apr 2024
0:59
What challenges are there in using CAR-T cells for solid tumors?
Leonardo Ferreira • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals